Table 3.

Diagnostic follow-up of abnormal mammograms^a and cancer detection rates^b among women by age group and mammogram indication, National Breast and Cervical Cancer Early Detection Program, 2009–2012

	Total (40–64 years)		40–49 years		50–64 years
	n	Per 1,000	n	Per 1,000	n	Per 1,000
Indication of screening
Total	941,649	1,000.0	284,110	1,000.0	657,539	1,000.0
Any diagnostic procedure
Yes	153,591	163.1	58,960	207.5	94,631	143.9
No	788,058	836.8	225,150	792.4	562,908	856.0
Breast biopsy
Yes	25,267	26.8	9,355	32.9	15,912	24.1
No	916,382	973.1	274,755	967.0	641,627	975.8
Invasive cancer or CIS
Yes	5,120	5.4	1,221	4.2	3,899	5.9
No	936,529	994.5	282,889	995.7	653,640	994.0
Invasive cancer
Yes	3,036	3.2	651	2.2	2,385	3.6
No	938,613	996.7	283,459	997.7	655,154	996.3
Carcinoma in situ
Yes	2,084	2.2	570	2.0	1,514	2.3
No	939,565	997.7	283,540	997.9	656,025	997.6
Indication of diagnostic
Total	175,310	1,000.0	82,397	1,000.0	92,913	1,000.0
Any diagnostic procedure
Yes	122,668	699.7	62,704	760.9	59,964	645.3
No	52,642	300.2	19,693	239.0	32,949	354.6
Breast biopsy
Yes	29,576	168.7	13,986	169.7	15,590	167.7
No	145,734	831.2	68,411	830.2	77,323	832.2
Invasive or CISc
Yes	11,871	67.7	3,943	47.8	7,928	85.3
No	163,439	932.2	78,454	952.1	84,985	914.6
Invasive cancer
Yes	9,326	53.1	3,023	36.6	6,303	67.8
No	165,984	946.8	79,374	963.3	86,610	932.1
Carcinoma in situ
Yes	2,545	14.5	920	11.1	1,625	17.4
No	172,765	985.4	81,477	988.8	91,288	982.5

^aAbnormal mammograms include suspicious abnormality, highly suggestive of malignancy, or assessment incomplete

^bRates are calculated per 1,000 mammograms

^cCarcinoma in situ